Antibiotic overconsumption and resistance in Turkey

Slides:

Advertisements

Similar presentations

Gram-positive infections: lessons learnt and novel solutions

Advertisements

C. Hauck, E. Cober, S. S. Richter, F. Perez, R. A. Salata, R. C

Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors S. Amit, H. Mishali, T. Kotlovsky,

Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis E.V. Lemos, F.P. de la Hoz,

G. Cornaglia, A. Lönnroth, M. Struelens

M.F.Q. Kluytmans-VandenBergh, J.A.J.W. Kluytmans

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years.

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

Migrant health—a cause for concern?

European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.

Use of a multiplex PCR-based reverse line blot (mPCR/RLB) hybridisation assay for the rapid identification of bacterial pathogens Y. Wang, F. Kong, G.L.

Clinical impact of antibiotic-resistant Gram-positive pathogens

Cost-effectiveness of universal MRSA screening on admission to surgery

Clonal complex 398 methicillin-susceptible Staphylococcus aureus bloodstream infections are associated with high mortality K. Bouiller, H. Gbaguidi-Haore,

Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries J.A. Otter, N.T. Mutters, E. Tacconelli, A.

European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.

Clinical impact and prevalence of MRSA CC398 and differences between MRSA-TetR and MRSA-TetS in an area of Spain with a high density of pig farming: a.

Longitudinal investigation of nasopharyngeal methicillin-resistant Staphylococcus aureus colonization in early infancy: The PATCH birth cohort study

Hospital Acquired Infections

Characterizing non-linear effects of hospitalisation duration on antimicrobial resistance in respiratory isolates: an analysis of a prospective nationwide.

Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012 V.

Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit K. Thorburn,

Appropriate vs. inappropriate antimicrobial therapy

W. Witte, B. Pasemann, C. Cuny Clinical Microbiology and Infection

A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals M. Nagao Clinical Microbiology and.

H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi

Pharmacodynamics of doxycycline

Do we need new antibiotics?

The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System M.E.A. de Kraker, V. Jarlier,

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

D. Esel, B. Sümerkan, S. Kocagöz Clinical Microbiology and Infection

A variant of the Southern German clone of methicillin-resistant Staphylococcus aureus is predominant in Croatia A. Budimir, R.H. Deurenberg, Z. Bošnjak,

Bacterial resistance—the clinical challenge

The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β- lactam administration and therapeutic drug monitoring among critically.

Strategies for managing today's infections

Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis R. Diaz, V. Afreixo,

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Levofloxacin in the treatment of ventilator-associated pneumonia

R. Bitterman, M. Paul, D. Polak, Y. Geffen

M. Aires-de-Sousa Clinical Microbiology and Infection

J. Buijs, A. S. M. Dofferhoff, J. W. Mouton, J. H. T. Wagenvoort, J. W

O. Murillo, I. Grau, J. Lora-Tamayo, J. Gomez-Junyent, A. Ribera, F

The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae J.M. Sierra,

T.M. File Clinical Microbiology and Infection

G. Birgand, L. S. P. Moore, C. Bourigault, V. Vella, D. Lepelletier, A

Systematic review of antibiotic consumption in acute care hospitals

Pandemic lineages of extraintestinal pathogenic Escherichia coli

A.W. Karchmer Clinical Microbiology and Infection

P.M. Hawkey Clinical Microbiology and Infection

Evolving problems with resistant pathogens

Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan

C. Gagliotti, L. Nobilio, M.L. Moro

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

P. Kaltsas, S. Want, J. Cohen Clinical Microbiology and Infection

Clinical Microbiology and Infection

J.-M. Rolain, C. Abat, P. Brouqui, D. Raoult

Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013 A. Badura, G. Feierl, G. Pregartner,

Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search.

J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T

A. Manzur, F. Gudiol Clinical Microbiology and Infection

Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory

B.A. Cunha Clinical Microbiology and Infection

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

D.A. Robinson, M.C. Enright Clinical Microbiology and Infection

Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3- ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant.

CMI readers' survey Clinical Microbiology and Infection

Presentation transcript:

Antibiotic overconsumption and resistance in Turkey B. Isler, Ş. Keske, M. Aksoy, Ö.K. Azap, M. Yilmaz, S.Ş. Yavuz, G. Aygün, E. Tigen, H. Akalın, A. Azap, Ö. Ergönül Clinical Microbiology and Infection Volume 25, Issue 6, Pages 651-653 (June 2019) DOI: 10.1016/j.cmi.2019.02.024 Copyright © 2019 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Average antibiotic resistance proportions in 2015 for eight high-priority antibiotic–bacterium combinations for selected OECD and non-OECD (*) countries [3]. FREC, fluoroquinolone-resistant Escherichia coli; VRE, vancomycin-resistant Enterococcus faecium and E. faecalis; 3GCREC, third-generation cephalosporin-resistant E. coli; CRKP, carbapenem-resistant Klebsiella pneumoniae; 3GCRKP, third-generation cephalosporin-resistant K. pneumoniae; CRPA, carbapenem-resistant Pseudomonas aeruginosa; MRSA, methicillin-resistant Staphylococcus aureus; PRSP, penicillin-resistant Streptococcus pneumoniae; CRAB, carbapenem-resistant Acinetobacter baumannii. Clinical Microbiology and Infection 2019 25, 651-653DOI: (10.1016/j.cmi.2019.02.024) Copyright © 2019 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 Proportion of antibiotics in family physician (FP) prescriptions. Clinical Microbiology and Infection 2019 25, 651-653DOI: (10.1016/j.cmi.2019.02.024) Copyright © 2019 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions